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Original Paper
Spatial and sustained attention in relation to
smoking status: behavioural performance and
brain activation patterns
Simone Vossel1, Tracy Warbrick1,2, Arian Mobascher1,3,
Georg Winterer1,4 and Gereon R Fink1,5
Abstract
Nicotine enhances attentional functions. Since chronic nicotine exposure through smoking induces neuroadaptive changes in the brain at a structural
and molecular level, the present functional MRI (fMRI) study aimed at investigating the neural mechanisms underlying visuospatial and sustained
attention in smokers and non-smokers. Visuospatial attention was assessed with a location-cueing paradigm, while sustained attention was measured
by changes in response speed over time. During invalid trials, neural activity within the basal forebrain was selectively enhanced in smokers and higher
basal forebrain activity was associated with increased parietal cortex activation. Moreover, higher levels of expired carbon monoxide in smokers before
scanning were associated with higher parietal cortex activation and faster responses to invalidly cued targets. Smokers showed a slowing of responses
and additionally recruited an area within the right supramarginal gyrus with increasing time on task. Activity decreases over time were observed in
visual areas in smokers. The data provide evidence for altered attentional functions in smokers as compared with non-smokers, which were partly
modulated by residual nicotine levels and were observed at a behavioural level for sustained and at a neural level for spatial and sustained attention.
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Introduction
The brain’s cholinergic neurotransmitter system emanating
predominantly from neurons in the basal forebrain, the
pontomesencephalon and the striatum, is critically involved
in attentional functions. It has been shown that nicotine,
which binds to the cholinergic nicotinic receptors in the
brain, can enhance both visuospatial and sustained attention
(see e.g. Hahn et al., 2009; Heishman et al., 2010; Mancuso
et al., 1999; Newhouse et al., 2004; Rezvani and Levin, 2001).
In non-smokers (Thiel et al., 2005; Thiel and Fink, 2008;
Vossel et al., 2008) and smokers (Murphy and Klein, 1998;
Witte et al., 1997) nicotine facilitates the detection of stimuli
when attention has been misdirected by invalid spatial cues in
the location-cueing paradigm (i.e. it speeds attentional reor-
ienting in space) (Posner, 1980). Moreover, nicotine has been
shown to reduce omission errors and response time (RT) var-
iability in the Continuous Performance Test (CPT) (Levin
et al., 1998) and the Rapid Visual Information Processing
(RVIP) task (Lawrence et al., 2002) which both assess the
ability to sustain attention over longer periods of time (see
Heishman et al., 2010 for a review).
The combination of functional MRI (fMRI) with psycho-
pharmacological challenges allows for the in vivo characteri-
zation of pharmacological modulations of task-related neural
activity (Honey and Bullmore, 2004). Pharmacological fMRI
studies in non-smokers have repeatedly shown that nicotine-
induced faster reorienting to invalidly cued targets in the
location-cueing paradigm is accompanied by reduced activity
in parietal brain regions (Giessing et al., 2006; Thiel et al.,
2005; Thiel and Fink, 2008; Vossel et al., 2008), presumably
reflecting more efficient information processing under
nicotine due to enhanced cholinergic signalling. In contrast,
one study in smokers has reported opposite effects of nicotine
(i.e. increased activity) in attention-related parietal brain
areas during the RVIP task (Lawrence et al., 2002).
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This may point to different actions of nicotine in smoking and
non-smoking subjects at the neural level.
Chronic nicotine exposure through cigarette smoking has
been shown to induce neuroadaptive changes in the brain
(see e.g. Ferrea and Winterer, 2009 for a recent review). For
instance, it has been observed that grey matter volumes in
prefrontal and cingulate brain regions are reduced in smokers
as compared with non-smokers, which might reflect effects of
chronic smoking (or alternatively predisposing traits that lead
to smoking, or a combination of these factors (Brody et al.,
2004)). At the receptor level, in vitro studies have shown that
nicotinic acetylcholine receptors in the brain (in particular
a2b4 and a7 subtypes) are increased and upregulated in
response to chronic nicotine exposure or chronic smoking
(Buisson and Bertrand, 2002; Perry et al., 1999; Staley
et al., 2006).
Despite this evidence for smoking-related brain changes at
an anatomical and receptor level, there is so far no clear
evidence for performance differences between smokers and
non-smokers in attentional tasks under drug-free conditions
(Hahn et al., 2007, 2009; Lawrence et al., 2002), although
performance decrements in smokers as compared with
never-smokers have occasionally been reported (Foulds
et al., 1996). These between-group differences may crucially
depend on the smokers’ deprivation status (and hence on
residual bodily levels of nicotine present in smokers, but not
in non-smokers) (Parrott et al., 1996). For example, it has
been shown that the time needed to reorient attention in the
location-cueing paradigm increases with the duration of
smoking abstinence and with salivary levels of the nicotine
metabolite cotinine (Shirtcliff and Marrocco, 2003).
Furthermore, little is known about baseline differences in
attention task-related neural activation patterns of smokers
and non-smokers under drug-free conditions. Here, Lawrence
et al. (2002) observed reduced activity in parietal brain
regions in smokers as compared with non-smokers when
smokers were nicotine-free for 2.5 hours.
Thus, the aim of the present study was twofold: first, it was
intended to investigate visuospatial attention in the location-
cueing paradigm as well as sustained attentional functions
(as reflected in the ability to maintain a constant level of
performance over time) in non-smokers and mildly deprived
smokers. Here, both behavioural performance and brain acti-
vation patterns were recorded. Second, the relationship
between these measures and residual nicotine levels
(as indexed by levels of expired carbon monoxide (CO)
before scanning) was examined to test for nicotine-dependent
behavioural and neural effects in the group of smokers.
Materials and methods
Subjects
Twenty-five subjects gave written informed consent to partic-
ipate in the study after having received detailed instructions
and explanations regarding the study. The subjects were
investigated in the context of a multi-session pharmacological
fMRI study (ClinicalTrials.gov Identifier: NCT00618280).
The analyses presented here focus on the first experimental
session and on the placebo condition only as part of an
interim analysis. The study was conducted in compliance
with the ethical principles of the World Medical Association
(Declaration of Helsinki) and was approved by the ethics
committee of the Heinrich-Heine University Du¨sseldorf and
the federal drug agency of Germany (Bundesinstitut fu¨r
Arzneimittel und Medizinprodukte). All subjects were
recruited from a large population-based database in
Germany and had no history of medical, neurological or
psychiatric illness or alcohol or drug abuse as assessed by a
full medical interview and examination, routine laboratory
tests, a drug screening test, an electrocardiogram and a stan-
dardized psychiatric interview (SCID) (First et al., 1995).
Subjects were moreover excluded from the study if they met
the following criteria: age below 18 or above 55 years, intake
of medication, participation in other pharmacological studies,
positive urine drug screening (cannabis, amphetamines,
opiates and cocaine), drug abuse during the last 6 months;
for women additionally: pregnancy, lactation. Alcohol abuse
was additionally assessed with the Alcohol Use Disorder
Identification Test (AUDIT) (Saunders et al., 1993).
Smokers were required to have a score 4 in the
Fagerstro¨m Test for Nicotine Dependence (FTND)
(Heatherton et al., 1991), non-smokers were defined by 20
cigarettes per lifetime. Simultaneous EEG recordings were
conducted during fMRI scanning. EEG data will not be
reported in the current study. Two subjects had to be
excluded from further analyses due to excessive movement
or technical problems during scanning, respectively.
Therefore, data from 23 subjects were analyzed. Of these,
13 subjects were non-smokers (7 females, 6 males, mean
age standard deviation (SD): 32.1 9.24 years). Ten
subjects were smokers (6 females, 4 males, mean age SD:
36.3 12.5 years; mean FTND score SD: 5.2 1.6, range
4–8) who had smoked on average for 19.9 12.8 years. The
smokers reported to smoke on average 17 6 (range from
7–25) cigarettes per day. Data from the AUDIT were avail-
able for 10 of the 13 non-smokers and for all smokers and
revealed that the two groups did not significantly differ in
their AUDIT score (non-smoker: mean SD: 4.6 5.1;
smokers: 2.9 1.7; t(18)¼ 0.99, p¼ .333). With the exception
of one ambidextrous subject in the group of non-smokers, all
subjects were right-handed.
The subjects were allowed to smoke their last cigarette
2 hours before the start of the experiment. Subjects were
not required to smoke, but were told that they were now
given the last opportunity to have a cigarette. Craving was
assessed with the Questionnaire on Smoking Urges (QSU)
(Tiffany and Drobes, 1991). Levels of CO in the breath of
the subjects were measured using a Micro 4 Smokerlyzer
(Bedfont Scientific Ltd.) 2 hours before the start of the exper-
imental task in the MRI scanner (i.e. after they were given the
last opportunity to smoke). Blood samples were collected for
cotinine immunoassay measurements (DRI Cotinine Assay,
Microgenics, Passau, Germany).
Stimuli and experimental paradigm
We employed a location-cueing task with central cues
(Posner, 1980). The stimuli were shown on a thin-film tran-
sistor (TFT) monitor behind the MR scanner and were
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presented to the subjects by means of a mirror-system.
Viewing distance was approximately 245 cm. Subjects were
presented with two horizontally arranged boxes (1 wide
and 4 eccentric in each visual field). A central diamond
(0.5 eccentric from the centre to the left and right edge of
the diamond) was placed in between, serving as a fixation
point. These elements constituted the baseline display and
were shown on the screen throughout the experiment. Cues
consisted of a 200ms brightening of one side of the diamond
depicting an arrowhead pointing to one of the peripheral
boxes. After a variable cue-target interval of 700 or 1000ms
the cue was followed by the presentation of the target (a black
diamond) appearing for 100ms in one of the two lateral
boxes. The cues were valid in 80% of the trials. Subjects
were instructed to respond as quickly as possible to the
target by a button press with the index finger of their right
hand. Trials were presented in a randomized sequence, every
3200ms. Approximately one third of the trials were
‘null events’ (Josephs and Henson, 1999) where the baseline
stimulus was displayed, leading effectively to variable stimu-
lus onset asynchronies (SOAs). In addition to validly and
invalidly cued trials we included catch trials in which the
cue was not followed by any target to prevent anticipatory
responses to the cues. The experiment consisted of 284 trials
(144 valid, 36 invalid and 14 catch trials), including 90 null
events, and lasted for 15minutes. Prior to performing the
task in the MR scanner the subjects were informed about
the different conditions and completed a short practice
session.
Data acquisition
T2*-weighted echoplanar (EPI) images with blood oxygen
level-dependent (BOLD) contrast (matrix size 64 64,
voxel size 3.1 3.1 3.0mm3, field of view (FOV)
200mm 200mm, 90 flip angle) were obtained using a 3T
MRI System (Trio, Siemens, Erlangen, Germany). Additional
high-resolution anatomical images (voxel size 1 1 1mm3)
were acquired using a standard T1-weighted 3D magnetisa-
tion prepared rapid gradient echo (MP-RAGE) sequence
(176 sagittal slices, repetition time/echo time 2250/3.03ms,
matrix size 64 64, FOV 200mm 200mm, 9 flip angle).
Four hundred and sixty-five EPI volumes of thirty-three
3mm thick axial slices were sequentially acquired (repetition
time 2.0 s, echo time 30ms). The first five volumes were dis-
carded to allow for T1 equilibration effects. The data were
pre-processed and analyzed with Statistical Parametric
Mapping software SPM5 (Wellcome Department of
Imaging Neuroscience, London) (Friston et al., 1995). To
correct for interscan movement, the images were spatially
realigned to the first of the remaining 460 volumes and sub-
sequently re-realigned to the mean of all images. Then the
mean EPI image for each subject was computed and spatially
normalized to the standard EPI template volume in SPM5.
The resulting normalization parameters (which define the
transformations that are necessary to move the subject’s
data into the Montreal Neurological Institute (MNI) stan-
dard coordinate space) were subsequently applied to the indi-
vidual EPI volumes as well as to the T1 scan, which had been
coregistered to the mean of the realigned EPIs beforehand.
The functional images were hereby transformed into standard
stereotaxic space and resampled at 2 2 2mm3 voxel size.
The normalized images were spatially smoothed using an
8mm full-width half-maximum (FWHM) Gaussian kernel
to meet the statistical requirements of the General Linear
Model and to compensate for residual macroanatomical var-
iations across subjects.
Statistical analysis of imaging data
Data were analyzed with SPM5 employing a random effects
model. Four regressors were defined at the single-subject level
(validly and invalidly cued targets, catch trials and missed/
incorrect responses). The event types were time-locked to the
onset of the target by a canonical synthetic hemodynamic
response function (hrf) and its first order temporal derivative.
The six movement parameters of the realignment (rigid body
translation in the x-, y- and z-plane as well as rotation around
the x-, y- and z-axis) were included in the design matrix as
additional regressors. Data were scan-wise globally scaled to
reduce globally distributed confounding effects (Kiebel and
Holmes, 2004) and high-pass filtered at 1/128Hz.
To investigate the neural correlates of spatial attention,
two contrast images (valid and invalid trials vs. baseline)
were created for each subject. These first-level contrast
images were entered into a 2 2 ANOVA model with the
within-subject factor ‘cueing’ (valid, invalid) and the
between-subject factor ‘group’ (non-smoker, smoker).
Although there were no significant differences in age
(t(21)¼0.93; p¼ 0.362) or gender (2¼ 0.87; p¼ 0.768),
these variables were included as covariates in this analysis to
account for the yet imperfect matching of the two groups.
Inhomogeneity of variance and correlation of measurement
were estimated with a Restricted Maximum Likelihood
(ReML) algorithm. We tested for main effects of cueing and
group, as well as for interaction effects with non-directional F-
contrasts (see Figure 1). Activations are reported at a level of
p< 0.001 (uncorrected). Since cluster-level inference is only
implemented for t-, but not for F-contrasts in SPM (Poline
et al., 1997), we employed a cluster extent threshold of more
than 30 contiguous 2 2 2mm3 voxels in order to minimize
the chance of false positive findings.
To test for linear increases and decreases of neural activity
over the time of the experiment, we employed a time modu-
lation of single-trial BOLD responses as implemented in
SPM5. For this analysis, a parametric regressor was added
for valid and invalid trials at the single-subject level which
coded for a linear relationship of BOLD amplitudes and time
(irrespective of experimental condition). Contrast images
were created for this parametric time regressor for the indi-
vidual subjects (one-zero contrast; time regressor vs. baseline)
providing information in which voxels BOLD amplitudes are
linearly associated with time. These contrast images were then
entered into a second-level ANOVA with the covariates age
and gender. We tested for differential effects between the two
experimental groups with a non-directional F-contrast isolat-
ing brain regions that show stronger activity increases or
decreases over time in smokers as compared to non-smokers.
Activations from this analysis are reported at a level of
Vossel et al. 1487
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p< 0.001 (uncorrected) and a cluster threshold of more than
30 contiguous voxels.
Since CO levels were significantly correlated with RTs to
invalidly cued targets in smokers (see the Results section),
a regression analysis between those values and neural activ-
ity during invalid trials was performed. A non-directional
F-contrast was used to test for relationships between BOLD
amplitudes and expired CO. Results from this analysis are
reported at a significance level of p< 0.001 and a cluster
threshold of more than 30 contiguous voxels. Post-hoc partial
Pearson correlations (rp) were calculated for significant voxels
to control for the effects of RT. Here, the voxel values (beta
parameters) of the peak activation voxels were considered.
Although no significant relationship between CO levels and
the trial number regression weights on RTs were obtained
(see below and Results section), we conducted exploratory
analogical regression and correlation analyses for the para-
metric time regressor (significance level of p< 0.001 and a
cluster threshold of more than 30 contiguous voxels).
For a further (post-hoc) analysis in the group of smokers,
we tested for a relationship between basal forebrain activity
(which was enhanced during invalid trials in smokers, see
Results section) and the activity in other brain areas. Here,
beta parameters of the regressor for invalid trials were
extracted at the peak voxel showing the cueing group inter-
action effect1 for each individual smoking subject and entered
as a regressor in a whole-brain random effects regression anal-
ysis. A non-directional F-contrast (thresholded at <0.001 and
a cluster extent of more than 30 voxels) tested for associations
between neural activity in the basal forebrain and other
regions in the brain.
Statistical analysis of behavioural data
RTs faster than 100ms (i.e. anticipated responses) (Luce,
1986) were excluded from the analysis. Median RTs were
calculated separately for valid and invalid trials in each
subject. Omissions were summed-up separately for valid and
invalid trials and expressed as percentage values. For the
‘catch trials’, false alarm responses were determined and
Figure 1. (A) Neural activity related to attentional reorienting in the location-cueing paradigm (main effect of cueing). (B) Brain regions showing
condition-unspecific activation differences between non-smokers and smokers (main effect of group). (C) Interaction effect of cueing and group. MNI
x-, y- and z-coordinates for the activations are provided on top of the bar charts. Asterisks denote where beta parameters significantly differ from zero.
v: valid; i: invalid; NS: non-smokers; S: smokers.
1Note that this voxel was excluded from the analysis by a mask, since
here the activity perfectly correlates with the input regressor.
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transformed into percentage values. To test for differences in
visuospatial attention in non-smokers and smokers, median
RTs and missed responses were analyzed with 2 2 ANOVAs
with the within-subjects factor ‘cueing’ (valid, invalid) and the
between-subject factor ‘group’ (non-smoker, smoker) (as well
as age and gender as covariates). False alarm responses in
catch trials were compared between both groups with one-
way ANOVAs (including age and gender as covariates).
To assess the ability to sustain attention over the time
course of the experiment, regression analyses with single-
trial RTs (irrespective of condition) as dependent and trial
number as independent variable were calculated in each indi-
vidual subject. The resulting regression weight (beta coeffi-
cient) of the trial number variable for each subject was
compared between non-smokers and smokers with a
one-way ANOVA (and age and gender as covariates)2.
In the smoker group, correlation analyses were performed
between levels of expired CO and RTs, percentage of omis-
sions and the time on task regression weights using
Spearman’s rank coefficient (rs). All results are reported at a
significance level of p< 0.05.
Results
Physiological and subjective measures
Cigarette craving was rated by the smoking subjects on a
7-point Likert-scale (1 (strongly disagree) to 7 (strongly
agree)) in the QSU. Here, smokers rated their urge to
smoke on average with 3.2 (0.76 SD). Levels of CO in the
subjects’ breath amounted on average to 17.3 9.8 ppm in
smokers (all values 4) and to 0.38 0.9 ppm in non-smokers
(CO¼ 0 in n¼ 10, CO¼ 1 in n¼ 2 and CO¼ 3 in n¼ 1
subject(s)). Blood cotinine levels amounted to 143 ng/
ml 102.2 and cotinine levels were highly correlated with
levels of expired CO in the group of smokers (rs¼ 0.94;
p< 0.0001). None of the other correlations between levels of
expired CO, blood cotinine levels, FTND score, cigarettes per
day, and QSU scores reached significance. The data from
three non-smokers could not be analysed for technical
reasons, but cotinine levels amounted to 0 in all of the
remaining non-smoking subjects (n¼ 10).
Behavioural data
Anticipations (RTs< 100ms) and false alarms (catch trials)
amounted to 0.00 0.00% and 0.21 0.36% in non-smokers
versus 0.00 0.00% and 0.22 0.54% in smokers, respec-
tively. No differences between the two groups were observed
for anticipations and false alarm rates (2p¼ 0.001). Missed
responses in valid trials amounted to 2.24 1.93% in
non-smokers and to 4.58 4.29% in smokers. In invalid
trials, non-smokers and smokers missed 2.35 2.49% and
4.72 7.75% of the targets, respectively. There was a trend
towards a higher percentage of missed responses in smokers
as compared with non-smokers (main effect of group:
F(1,19)¼ 3.871; p¼ 0.064; 2p¼ 0.169) as well as a trend
towards a higher proportion of missed responses in invalid
as compared with valid trials (main effect of cueing:
F(1,19)¼ 3.864; p¼ 0.064; 2p¼ 0.169). The cueing group
interaction did not reach significance (2p¼ 0.012). Averaged
median RTs SDs in valid and invalid trials were
340.83 44.8ms and 383.52 48.7ms in non-smokers
versus 337.75 50.0ms and 391.19 70.0ms in smokers,
respectively. The 2 (valid, invalid) 2 (non-smoker, smoker)
ANOVA revealed a significant main effect of cueing
(F(1,19)¼ 8.752; p¼ 0.008) indicating slower responses to
invalidly as compared with validly cued targets. Neither the
main effect of group nor the group cueing interaction effect
reached significance (2p¼ 0.001 and 0.056, respectively).
Within the group of smokers, CO levels were significantly
correlated with the percentage of missed responses in invalid
trials (rs¼0.67; two-sided p¼ 0.034) and by trend also with
RT to invalidly cued targets (rs¼0.62; two-sided p¼ 0.056)
(see Figure 2A). No significant correlations with missed
responses or RT in valid trials were obtained. When levels
of cotinine were considered, significant correlations were
observed for both behavioural measures (misses in invalid
trials: rs¼0.68; two-sided p¼ 0.03; RT invalid trials:
rs¼0.83; two-sided p¼ 0.003). No significant relationship
between behavioural performance and any of the other smok-
ing-related variables (FTND, QSU, and cigarettes per day)
were observed.
The ANOVA on the trial number regressor (coding for
linear increases or decreases in RTs across the time of the
experiment) revealed higher values for smokers than for
non-smokers (F(1,19)¼ 4.423; p¼ 0.049). In particular, nega-
tive values close to zero (mean SD: 0.082 0.43) indicat-
ing constant or even slightly reduced RTs with longer time on
task were observed for non-smokers, while smokers showed
positive values reflecting an increase in RTs towards the end
of the experiment (0.307 0.57) (see Figure 3A). In smokers,
the correlation between CO levels and the trial number regres-
sor did not reach significance (rs¼0.395; two-sided
p¼ 0.260; for cotinine levels: rs¼0.43; two-sided
p¼ 0.214). The trial number regressor was also not signifi-
cantly related to other smoking-related variables such as the
FTND score or the number of cigarettes per day, while a
trend towards a significant positive correlation was observed
with the QSU scores (rs¼ 0.59; two-sided p¼ 0.074).
Neural data – spatial attention
Table 1 lists those regions in the brain where significant main
effects of cueing and group as well as cueing group interac-
tion effects were observed.
The contrast of invalidly versus validly cued targets (main
effect of cueing) revealed activation within fronto-parietal
brain regions predominantly in the right hemisphere
(see Table 1 and Figure 1A). In all regions, neural activity
was higher in invalid as compared with valid trials. Two brain
2The same analyses were repeated with a separate modelling of trial
number, condition (valid; invalid) and the interaction effect, to assess
whether RTs to validly and invalidly cued targets differentially varied
with increasing time on task between the two groups. Here, no
significant interactive effects were observed, so that the condition
factor was also not considered in the time modulation analyses of
BOLD signals.
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areas (within the left supplementary motor area (SMA) and
the right posterior middle cingulate gyrus) showed a
main effect of group indicating a condition-unspecific differ-
ence in neural activity in the two experimental groups
(see Table 1). While the SMA was more strongly activated,
the posterior middle cingulate gyrus was less deactivated in
smokers than in non-smokers (see Figure 1B). An interaction
effect was observed within the right basal forebrain. Here,
activity was enhanced for invalid as compared with valid
trials in smokers, but not in non-smokers (see Figure 1C).
The regression analysis between neural activity in invalid
trials and levels of expired CO before scanning revealed three
regions within left and right parietal cortex where BOLD
amplitudes were positively correlated with CO values (right
angular gyrus: x¼ 48, y¼52, z¼ 52; F¼ 53.82; 142 voxels;
left angular gyrus: x¼46, y¼54, z¼ 52; F¼ 62.94; 39
voxels; right supramarginal gyrus: x¼ 44, y¼36, z¼ 44;
F¼ 77.28; 42 voxels; see Figure 2B). All three regions also
showed significant correlation with blood cotinine levels.
No negative correlations were observed. Post-hoc partial
correlation analyses between the beta parameters (as indica-
tors of BOLD amplitudes) and the CO values showed that the
relationship persisted in the left angular gyrus (rp¼ 0.69,
t(7)¼ 2.54, two-sided p¼ 0.039) and the right supramarginal
gyrus (rp¼ 0.69, t(7)¼ 2.52, two-sided p¼ 0.04), but not in the
right angular gyrus (rp¼ 0.59, t(7)¼ 1.95, two-sided p¼ 0.092)
when the effect of RTs in invalid trials (which significantly
correlated with CO levels) was controlled.
Neural data – sustained attention
The ANOVA on the time modulation regressor revealed
several brain regions where neural activity differentially
increased or decreased with time on task in smokers and
non-smokers (see Table 2 and Figure 3B). Here, activity in
the anterior cingulate gyrus, the superior temporal pole, the
Figure 2. (A) Relationship between CO levels and reaction times in invalid trials as well as missed responses in the group of smokers. (B) Results of the
regression analysis of expired CO levels before scanning and BOLD amplitudes in invalid trials.
1490 Journal of Psychopharmacology 25(11)
 at Forschungszentrum Julich Gmbh on May 13, 2013jop.sagepub.comDownloaded from 
posterior insular cortex, the lingual gyrus and middle
occipital gyrus and the cuneus decreased across time in
smokers more than in non-smokers, while the opposite
effect (i.e. activity increases with time in smokers
rather than non-smokers) was observed in the right supra-
marginal gyrus.
The regression analysis with expired levels of CO in
smokers did not yield any significant results.
Post-hoc regression analysis in smokers
The post-hoc regression analysis testing for a relationship
between the activity in the basal forebrain and the activity
in other brain areas during invalid trials yielded significant
correlations with (1) neighbouring regions of the basal fore-
brain (x¼ 18, y¼10, z¼10; F¼ 222.58; 52 voxels), (2) the
right insular cortex (x¼ 42, y¼ 12, z¼2; F¼ 71.05; 74
Figure 3. (A) Mean response times and standard deviations over the time course of the experiment for non-smokers (left) and smokers (right). Note
that differences in the slope of the trial number regressor were statistically significant. (B) Brain areas where neural activity decreased (blue) or
increased (orange) with time in smokers more than in non-smokers.
Table 1. Results of the cueing group ANOVA on the fMRI data
MNI coordinates
Region Side Effect x y z Voxels F
Main effect of cueing (invalid versus valid trials)
Inferior frontal gyrus R I> V 46 8 32 195 23.1
Precentral gyrus L I> V 28 14 48 41 24.4
Supplementary motor area R I> V 8 16 58 36 19.6
Inferior parietal cortex R I> V 34 42 44 83 28.2
Superior parietal cortex R I> V 24 64 58 60 21.0
Main effect of group (non-smokers versus smokers)
Supplementary motor area L S>NS 2 4 74 49 21.7
Middle cingulate gyrus R S>NS 8 36 40 32 20.6
Cueing group interaction
Basal forebrain R S (I> V)>NS (I> V) 18 8 10 103 32.9
R: right, L: left, I: invalid trials, V: valid trials, S: smokers, NS: non-smokers.
Vossel et al. 1491
 at Forschungszentrum Julich Gmbh on May 13, 2013jop.sagepub.comDownloaded from 
voxels), and (3) the right inferior parietal cortex (x¼ 48,
y¼58, z¼ 42; F¼ 74.18; 121 voxels) (see Figure 4).
Hence, activity in these areas was higher in smokers with
high basal forebrain activity during invalid trials.
Discussion
In the present study behavioural and neural correlates of
spatial and sustained attention were compared between
smoking and non-smoking subjects. Related to attentional
reorienting smokers did not show different RTs from
non-smokers. However, the basal forebrain was more
strongly recruited during invalid as compared to valid trials
by smokers. Higher levels of expired CO were associated with
faster RTs and higher neural activity within the bilateral
parietal cortex in invalid trials in smokers. Sustained atten-
tion was reduced in smokers as compared with non-smokers
as reflected in a reduced ability to maintain a constant
performance level throughout the time course of the experi-
ment. The latter effect was accompanied by both stronger
reductions in neural activity in brain areas such as, for exam-
ple, the visual cortex, as well as with a stronger recruitment of
the right supramarginal gyrus with increasing time on task in
smokers as opposed to non-smokers. Higher CO levels
reduced the percentage of omissions in invalid trials, but
did not significantly affect the RT slowing with increasing
time on task in smokers. In sum, the current findings provide
evidence for altered attentional functions in smokers which
are evident at a behavioural level for sustained and at a neural
level for both spatial and sustained attention.
Spatial attention
Reorienting visual attention in space activated a
right-lateralized fronto-parietal network as in previous
fMRI studies employing location-cueing paradigms
(Giessing et al., 2006; Thiel et al., 2004, 2005; Vossel et al.,
2006, 2008). These regions were likewise recruited by smokers
and non-smokers. However, smokers showed less deactivation
in the posterior part of the middle cingulate cortex during the
task irrespective of cueing condition. This region – which was
located at the border to the posterior cingulate cortex – has
been implicated in the default network of the brain (see e.g.
Fox and Raichle, 2007 for a review), since it usually shows
decreases in activity during goal-directed actions when
contrasted with passive viewing conditions. Moreover, deac-
tivation in this region has been related to relatively faster
response times, while reduced deactivation is associated with
momentary lapses of attention (Weissman et al., 2006). It has
also been shown that nicotine administration in smokers fur-
ther deactivates areas of the default network during a visuo-
spatial attention task (Hahn et al., 2007). The finding that this
area was less deactivated during task performance in the pre-
sent study may thus indicate less effective suspension of task-
irrelevant processes in mildly deprived smokers.
Interestingly, differential reorienting-related activity
between the two groups (i.e. a cueing group interaction
effect) was observed in the right basal forebrain where
neural activity was enhanced in invalid as compared with
valid trials in smokers, but not in non-smokers. The localiza-
tion of this region within the basal forebrain was confirmed by
cytoarchitectonic maps of this area according to which the
activation cluster in the present study lay within a sphere of
5mm from the centre of gravity of the Ch4 compartment
which incorporates the nucleus basalis of Meynert (Mesulam
et al., 1983; Zaborszky et al., 2008). The basal forebrain pro-
vides the major cholinergic input to the neocortex and has
been related to signal detection and top-down attention on
the basis of animal data (see Sarter et al., 2005 for a review).
In particular, lesions of the basal forebrain result in slowed
Table 2. Results of the time modulation comparison of neural activity in smokers versus non-smokers
Region Side Effect
MNI coordinates
Voxels Fx y z
Differential time modulation effect in non-smokers and smokers
Anterior cingulate gyrus R NS> S 2 28 4 34 20.5
Superior temporal pole R NS> S 56 16 12 39 29.0
Posterior insular cortex L NS> S 48 14 4 98 27.5
Middle occipital gyrus R NS> S 40 88 18 42 26.6
Lingual gyrus L NS> S 4 68 6 33 20.7
Cuneus R NS> S 2 76 24 51 19.2
Supramarginal gyrus R S>NS 40 32 38 33 22.4
R: right, L: left, NS: non-smokers, S: smokers.
Figure 4. Positive relationship between basal forebrain response and
neural activity in the right inferior parietal cortex in invalid trials in
smokers. BF: basal forebrain, IPL: inferior parietal lobe.
1492 Journal of Psychopharmacology 25(11)
 at Forschungszentrum Julich Gmbh on May 13, 2013jop.sagepub.comDownloaded from 
responses to invalidly cued stimuli in rats (Bushnell et al.,
1998) and monkeys (Voytko et al., 1994). It was proposed
that the corticopetal projections that arise from the basal fore-
brain influence the activity of frontal and parietal areas during
attentional tasks (Sarter et al., 2001, 2005). In the present
study, no significant activation differences between smokers
and non-smokers were observed in the fronto-parietal reor-
ienting network, although Lawrence et al. (2002) reported
less attention task-induced activation in parietal cortex in
smokers under placebo conditions. Our data thus suggest
that the basal forebrain might have enhanced the activity in
fronto-parietal areas in smokers during reorienting foreclosing
activity differences to non-smokers. This assumption was
tested with a post-hoc regression analysis. Although this anal-
ysis does not provide any information on the directionality of
the effects or on the possible role of a third modulatory vari-
able, it was observed that smokers with higher basal forebrain
activity during invalid trials tended to show higher activation
of the right inferior parietal cortex.
Parietal cortex activity during invalid trials in smokers was
also enhanced with higher levels of expired CO before scan-
ning resulting in faster responses to invalidly cued targets.
If the relationship between basal forebrain and parietal
cortex proved true, basal forebrain activation should likewise
be associated with higher CO levels and parietal activity,
accordingly. A post-hoc partial correlation analysis between
CO levels and the basal forebrain response in invalid trials
(at the voxel identified by the interaction effect of the
ANOVA), controlling for the effect of RT in invalid trials,
revealed a positive, but non-significant, relationship
(rp¼ 0.55; t(7)¼ 1.75; two-sided p¼ 0.12). In sum, these effects
suggest an additional recruitment of the basal forebrain in
smokers during attentional reorienting which possibly coun-
teracts differences in RTs and parietal cortex activity to
non-smokers and which might depend on (or be triggered
by) residual bodily levels of nicotine.
It has to be noted that the positive correlation between CO
levels (as an indicator of bodily nicotine levels) and the
parietal cortex response is directly opposed to the effects of
nicotine administration on reorienting-related parietal activa-
tion in non-smokers (Giessing et al., 2006; Thiel et al., 2005;
Thiel and Fink, 2008; Vossel et al., 2008). Here, nicotine
reduces BOLD amplitudes in parietal areas during invalid
trials. Thus, smokers and non-smokers seem to respond
differentially to nicotinic stimulation. Possibly, the underlying
mechanisms also differ, so that an enhancement of nicotine
levels above the normal level in non-smokers increases infor-
mation processing efficiency, whereas it prevents an atten-
tional decline in nicotine-deprived smokers. Further
evidence for enhanced attention-related parietal activity in
response to nicotine in smokers is provided by the study of
Lawrence et al. (2002). Here, neural activity within the bilat-
eral parietal cortex was increased in response to nicotine
administration in the sustained attention, but not in the
control task in smokers.
Sustained attention
When the stability of RTs over the time course of the exper-
iment was considered, smokers performed worse than
non-smokers in that they showed an increase in RTs with
increasing time on task. Hence, the ability to sustain attention
over longer time periods seemed to be compromised in mildly
deprived smokers. Here, the amount of missed responses in
invalid trials was negatively correlated with CO levels, while
no significant relationship was observed for RT increases
with time. Stronger activity decreases with time than in
non-smokers were observed in multiple brain areas and
amongst others in the visual cortex. It could be speculated
that this effect reflects difficulties in maintaining the
cue-induced top-down modulation of sensory areas
over time in smokers leading to the observed RT slowing.
In contrast, an area within the right supramarginal gyrus
was more strongly activated in smokers than in non-smokers
with increasing time on task. This region – which has previ-
ously been related to sustained attention by multiple studies
(see Singh-Curry and Husain, 2009 for a meta-analysis and
review) – might have been more strongly recruited with
increasing time on task and hence with increasing demands
to maintain an attentive state in smokers.
Limitations of the study
The sample sizes in the present study were relatively small, so
that the findings and particularly the correlative relationships
in the group of smokers need to be replicated with larger
groups. Moreover, the current study relied on levels of
expired CO as an indirect indicator of bodily nicotine levels
and plasma nicotine levels were not assessed. However, CO
levels were highly correlated with blood levels of the nicotine
metabolite cotinine and the association with behavioural and
fMRI measures was consequently also observed when blood
cotinine levels were considered. Moreover, previous studies
have shown that levels of expired CO are highly correlated
with blood nicotine levels (Herning et al., 1983; Haustein
et al., 2003; Jarvik et al., 2000).
Smokers in the current study were abstinent for 2 hours
prior to performing the task in the MR scanner which may
have induced mild withdrawal effects. Hence, although higher
CO levels are indicative of higher nicotine levels (which may
retard withdrawal), they might also be related to higher
smoking rates and higher nicotine dependency and thus to
higher withdrawal effects in smokers. In the following we
would like to speculate how the findings of the present
study are related to effects of nicotine or withdrawal due to
smoking deprivation, respectively. If the observed findings
were mediated by higher nicotine dependency and higher
withdrawal, we would expect correlations of the behavioural
and fMRI measures with smoking-related variables such as
the FTND score, the amount of cigarettes smoked per day, or
the amount of craving assessed with the QSU. Furthermore,
QSU scores in deprived smokers are usually higher than in the
current study (Tiffany and Drobes, 1991; Morgan et al.,
1999). In contrast to CO and cotinine levels, none of these
smoking-related variables was significantly related to the
reported neural and performance effects in the present
study. The only possible exception to this was the measure
of sustained attention, where we observed a trend towards a
significant correlation with the QSU scores. Thus, the
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performance decrement over the time of the experiment might
have been affected by beginning withdrawal in the group of
smokers.
Conclusion
In the present study smokers and non-smokers showed func-
tion-specific differences in attentional processing which were
evident at behavioural and neural levels and were partly
modulated by residual nicotine levels in the group of smokers.
During shifts of spatial attention, activity within the basal
forebrain was enhanced and correlated with parietal cortex
activation in smokers. Smokers showed a reduced ability to
maintain a constant level of performance throughout the
experiment, as well as differential increases and decreases in
neural activity with time on task when compared with
non-smokers. Moreover, both task performance and brain
activation patterns were critically affected by residual nicotine
levels as reflected by levels of expired CO in smokers.
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